cagrilintide purity - Certificates of Analysis Cagrilintide (10mg vials) - Peptide

Key distinctions from growth hormone include [5] : Peptide lacks growth hormone receptor binding domains (specifically binding site 2) Binding site 2 is required for receptor dimerization and activation Competitive binding assays showed AOD9604 cannot compete with hGH for receptor binding Does not function as a growth hormone receptor antagonist Glucose Metabolism Preservation Unlike full hGH, which can induce insulin resistance and hyperglycemia, AOD9604 demonstrates no adverse effects on carbohydrate metabolism

Some peptides may support the bodys natural repair processes, helping tissues recover more efficiently

Sterile Technique Proper hygiene prevents injection site infections

Anwar, A

Both peptides aim to reduce body weight and improve metabolic health through completely different biological mechanisms